Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic
© 2022 Geneuro Innovation SAS. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA..
OBJECTIVE: Human endogenous retroviruses have been implicated in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). Expression of human endogenous retrovirus K (HERV-K) subtype HML-2 envelope (Env) in human neuronal cultures and in transgenic mice results in neurotoxicity and neurodegeneration, and mice expressing HML-2 Env display behavioral and neuromuscular characteristics resembling ALS. This study aims to characterize the neurotoxic properties of HML-2 Env.
METHODS: Env neurotoxicity was detected in ALS cerebrospinal fluid and confirmed using recombinant Env protein in a cell-based assay and a mouse model. The mechanism of neurotoxicity was assessed with immunoprecipitation followed by mass spectrometry and Western blot, and by screening a panel of inhibitors.
RESULTS: We observed that recombinant HML-2 Env protein caused neurotoxicity resulting in neuronal cell death, retraction of neurites, and decreased neuronal electrical activity. Injection of the Env protein into the brains of mice also resulted in neuronal cell death. HML-2 Env protein was also found in the cerebrospinal fluid of patients with sporadic ALS. The neurotoxic properties of the Env and the cerebrospinal fluid could be rescued with the anti-Env antibody. The Env was found to bind to CD98HC complexed to β1 integrin on the neuronal cell surface. Using a panel of compounds to screen for their ability to block Env-induced neurotoxicity, we found that several compounds were protective and are linked to the β1 integrin pathway.
INTERPRETATION: HERV-K Env is released extracellularly in ALS and causes neurotoxicity via a novel mechanism. Present results pave the way for new treatment strategies in sporadic ALS. ANN NEUROL 2022;92:545-561.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:92 |
|---|---|
| Enthalten in: |
Annals of neurology - 92(2022), 4 vom: 01. Okt., Seite 545-561 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Steiner, Joseph P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Gene Products, env |
|---|
| Anmerkungen: |
Date Completed 20.09.2022 Date Revised 29.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ana.26452 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343219158 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343219158 | ||
| 003 | DE-627 | ||
| 005 | 20231226015925.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ana.26452 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1144.xml |
| 035 | |a (DE-627)NLM343219158 | ||
| 035 | |a (NLM)35801347 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Steiner, Joseph P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.09.2022 | ||
| 500 | |a Date Revised 29.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Geneuro Innovation SAS. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. | ||
| 520 | |a OBJECTIVE: Human endogenous retroviruses have been implicated in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). Expression of human endogenous retrovirus K (HERV-K) subtype HML-2 envelope (Env) in human neuronal cultures and in transgenic mice results in neurotoxicity and neurodegeneration, and mice expressing HML-2 Env display behavioral and neuromuscular characteristics resembling ALS. This study aims to characterize the neurotoxic properties of HML-2 Env | ||
| 520 | |a METHODS: Env neurotoxicity was detected in ALS cerebrospinal fluid and confirmed using recombinant Env protein in a cell-based assay and a mouse model. The mechanism of neurotoxicity was assessed with immunoprecipitation followed by mass spectrometry and Western blot, and by screening a panel of inhibitors | ||
| 520 | |a RESULTS: We observed that recombinant HML-2 Env protein caused neurotoxicity resulting in neuronal cell death, retraction of neurites, and decreased neuronal electrical activity. Injection of the Env protein into the brains of mice also resulted in neuronal cell death. HML-2 Env protein was also found in the cerebrospinal fluid of patients with sporadic ALS. The neurotoxic properties of the Env and the cerebrospinal fluid could be rescued with the anti-Env antibody. The Env was found to bind to CD98HC complexed to β1 integrin on the neuronal cell surface. Using a panel of compounds to screen for their ability to block Env-induced neurotoxicity, we found that several compounds were protective and are linked to the β1 integrin pathway | ||
| 520 | |a INTERPRETATION: HERV-K Env is released extracellularly in ALS and causes neurotoxicity via a novel mechanism. Present results pave the way for new treatment strategies in sporadic ALS. ANN NEUROL 2022;92:545-561 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 650 | 7 | |a Gene Products, env |2 NLM | |
| 650 | 7 | |a Integrin beta1 |2 NLM | |
| 700 | 1 | |a Bachani, Muzna |e verfasserin |4 aut | |
| 700 | 1 | |a Malik, Nasir |e verfasserin |4 aut | |
| 700 | 1 | |a DeMarino, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Wenxue |e verfasserin |4 aut | |
| 700 | 1 | |a Sampson, Kevon |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Myoung-Hwa |e verfasserin |4 aut | |
| 700 | 1 | |a Kowalak, Jeffery |e verfasserin |4 aut | |
| 700 | 1 | |a Bhaskar, Manju |e verfasserin |4 aut | |
| 700 | 1 | |a Doucet-O'Hare, Tara |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia-Montojo, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Cowen, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a Reoma, Lauren Bowen |e verfasserin |4 aut | |
| 700 | 1 | |a Medina, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Brunel, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Pierquin, Justine |e verfasserin |4 aut | |
| 700 | 1 | |a Charvet, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Perron, Hervé |e verfasserin |4 aut | |
| 700 | 1 | |a Nath, Avindra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of neurology |d 1983 |g 92(2022), 4 vom: 01. Okt., Seite 545-561 |w (DE-627)NLM000198420 |x 1531-8249 |7 nnns |
| 773 | 1 | 8 | |g volume:92 |g year:2022 |g number:4 |g day:01 |g month:10 |g pages:545-561 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ana.26452 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 92 |j 2022 |e 4 |b 01 |c 10 |h 545-561 | ||